Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 2/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6021113 | 1.00 | MEN1 (0.45) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL22971752 | 0.98 | MEN1 (0.41) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL22960180 | 0.93 | TSHR (0.44) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL8420927 | 0.86 | TSHR (0.39) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL19098226 | 0.82 | MEN1 (0.45) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL19098580 | 0.82 | MEN1 (0.45) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL14211509 | 0.82 | MEN1 (0.45) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL12257499 | 0.81 | LPAR3 (0.41) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL12257497 | 0.81 | LPAR3 (0.41) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL1839694 | 0.80 | MEN1 (0.43) | MEN1KMT2ATHRBHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4010327-B1 | ACID-LABILE SURFACTANTS | PROMEGA CORP (US) | 2024-10-02 | — | — | EP | disclosed |
| US-11939311-B2 | Acid-labile surfactants | PROMEGA CORPORATION (US) | 2024-03-26 | — | — | US | disclosed |
| EP-4010327-A1 | ACID-LABILE SURFACTANTS | Promega Corporation (US) | 2022-06-15 | — | — | EP | disclosed |
| US-20210040058-A1 | ACID-LABILE SURFACTANTS | PROMEGA CORPORATION | 2021-02-11 | — | — | US | disclosed |
| WO-2021026316-A1 | ACID-LABILE SURFACTANTS | PROMEGA CORPORATION (US) | 2021-02-11 | — | — | WO | disclosed |
| WO-2021026316-A1 | ACID-LABILE SURFACTANTS | PROMEGA CORPORATION (US) | 2021-02-11 | — | — | WO | disclosed |
| US-20210040058-A1 | ACID-LABILE SURFACTANTS | PROMEGA CORPORATION | 2021-02-11 | — | — | US | disclosed |
| US-8445223-B2 | Anionic acid-labile surfactants and methods of use | PROTEA BIOSCIENCES, INC. (US) | 2013-05-21 | — | — | US | disclosed |
| US-8445223-B2 | Anionic acid-labile surfactants and methods of use | PROTEA BIOSCIENCES, INC. (US) | 2013-05-21 | — | — | US | disclosed |
| US-8445223-B2 | Anionic acid-labile surfactants and methods of use | PROTEA BIOSCIENCES, INC. (US) | 2013-05-21 | — | — | US | disclosed |
| US-8232423-B2 | Anionic acid-labile surfactants and methods of use | PROTEA BIOSCIENCES, INC. (US) | 2012-07-31 | — | — | US | disclosed |
| US-20110282096-A1 | ANIONIC ACID-LABILE SURFACTANTS AND METHODS OF USE | PROTEA BIOSCIENCES, INC. | 2011-11-17 | — | — | US | disclosed |
| US-20110282096-A1 | ANIONIC ACID-LABILE SURFACTANTS AND METHODS OF USE | PROTEA BIOSCIENCES, INC. | 2011-11-17 | — | — | US | disclosed |
| US-20110282096-A1 | ANIONIC ACID-LABILE SURFACTANTS AND METHODS OF USE | PROTEA BIOSCIENCES, INC. | 2011-11-17 | — | — | US | disclosed |
| US-8013179-B2 | Anionic acid-labile surfactants and methods of use | PROTEA BIOSCIENCES, INC. (US) | 2011-09-06 | — | — | US | disclosed |
| US-8013179-B2 | Anionic acid-labile surfactants and methods of use | PROTEA BIOSCIENCES, INC. (US) | 2011-09-06 | — | — | US | disclosed |
| US-8013179-B2 | Anionic acid-labile surfactants and methods of use | PROTEA BIOSCIENCES, INC. (US) | 2011-09-06 | — | — | US | disclosed |
| US-20090292136-A1 | Anionic acid-labile surfactants and methods of use | SUMMIT RESOURCES, INC. | 2009-11-26 | — | — | US | disclosed |
| US-20090292136-A1 | Anionic acid-labile surfactants and methods of use | SUMMIT RESOURCES, INC. | 2009-11-26 | — | — | US | disclosed |
| US-20090292136-A1 | Anionic acid-labile surfactants and methods of use | SUMMIT RESOURCES, INC. | 2009-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110282096-A1 | ANIONIC ACID-LABILE SURFACTANTS AND METHODS OF USE | H1-0, H1-2, H1-3 | MEN1 2852/4885KMT2A 4108/4885THRB 4110/4885 |
| US-20090292136-A1 | Anionic acid-labile surfactants and methods of use | H1-0, H1-2, H1-3 | MEN1 1404/4885KMT2A 2621/4885THRB 3676/4885 |
| US-20210040058-A1 | ACID-LABILE SURFACTANTS | SMURF1, S100A6, SPAST | MEN1 3678/4885KMT2A 4671/4885THRB 3938/4885 |
| US-11939311-B2 | Acid-labile surfactants | SMURF1, S100A6, SPAST | MEN1 3678/4885KMT2A 4671/4885THRB 3938/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.